CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 20 8089 7893 support@capital.com

Handel BioMarin Pharmaceutical Inc - BMRN CFD

111.72
0.8%
0.88
Lav: 111.69
Høj: 113.28
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.88
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.030779%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.013666%
Gebyr natten over, tid 22:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Biomarin Pharmaceutical Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 112.62
Åben* 112.65
1-Års Ændring* 27.63%
Dagens Spænd* 111.69 - 113.28
52-Ugers Spænd 70.73-117.77
Gennemsnitlig Volumen (10 dage) 1.46M
Gennemsnitlig Volumen (3 måneder) 31.05M
Market Cap 20.85B
P/E-forhold 284.19
Udestående aktier 185.85M
Omsætning 2.01B
EPS 0.39
Dividend (Udbytte %) N/A
Beta 0.36
Næste indtjeningsopgørelse Feb 21, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Feb 3, 2023 111.72 -0.63 -0.56% 112.35 113.68 111.21
Feb 2, 2023 112.62 -3.05 -2.64% 115.67 116.34 111.50
Feb 1, 2023 116.50 2.14 1.87% 114.36 116.68 113.19
Jan 31, 2023 115.12 1.18 1.04% 113.94 115.38 113.94
Jan 30, 2023 114.47 -1.80 -1.55% 116.27 116.93 114.14
Jan 27, 2023 116.79 1.47 1.27% 115.32 117.56 115.32
Jan 26, 2023 116.58 1.07 0.93% 115.51 116.94 114.46
Jan 25, 2023 115.45 1.60 1.41% 113.85 116.29 113.84
Jan 24, 2023 113.39 3.30 3.00% 110.09 113.79 110.09
Jan 23, 2023 110.98 1.71 1.56% 109.27 111.38 108.74
Jan 20, 2023 110.47 1.35 1.24% 109.12 110.86 108.49
Jan 19, 2023 108.78 -1.10 -1.00% 109.88 109.96 108.60
Jan 18, 2023 110.28 -0.81 -0.73% 111.09 111.73 110.15
Jan 17, 2023 111.36 0.36 0.32% 111.00 112.79 109.88
Jan 13, 2023 112.27 1.12 1.01% 111.15 114.58 110.75
Jan 12, 2023 112.91 2.89 2.63% 110.02 113.43 108.97
Jan 11, 2023 110.68 -0.47 -0.42% 111.15 112.46 108.79
Jan 10, 2023 110.79 3.99 3.74% 106.80 111.79 106.11
Jan 9, 2023 106.58 -2.13 -1.96% 108.71 109.86 105.28
Jan 6, 2023 108.31 2.12 2.00% 106.19 109.07 106.19

BioMarin Pharmaceutical Inc Events

Time (UTC) Country Event
No events scheduled
View all events
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Total omsætning 1116.85 1313.65 1491.21 1704.05 1860.45 1846.28
Omsætning 1116.85 1313.65 1491.21 1704.05 1860.45 1846.28
Kost af omsætning, Total 209.62 241.786 315.264 359.466 524.272 470.515
Bruttofortjeneste 907.234 1071.86 1175.95 1344.58 1336.18 1375.76
Totale Driftsudgifter 1920.28 1328.35 1614.74 1804.51 1897.22 1928.62
Salgs/Generelle/Admin. Udgifter, Total 472.976 565.167 610.014 675.665 737.784 760.923
Forskning & Udvikling 661.905 610.753 696.328 715.007 628.116 628.793
Depreciation / Amortization 30.2 36.2 30.3 53.5 62.2 61.9
Renteudgift (Indkomst) - Netto Drift 3.617 -10.831 -5.661 5.259 -0.115 -1.548
Usædvanlig Udgift (Indkomst) 599.118 -125 -50 -25 -59.495 0
Other Operating Expenses, Total -57.153 10.271 18.491 20.608 4.458 8.033
Driftsindtægter -803.429 -14.7 -123.524 -100.457 -36.765 -82.341
Renteindkomst (Udgift), Netto Ikke-Drift -32.55 -29.145 -21.386 -1.299 -12.705 -4.855
Andre, Netto 4.929 7.97 2.205 6.945 7.148 11.846
Netto Indkomst Før Skat -831.05 -35.875 -142.705 -94.811 -42.322 -75.35
Netto Indkomst Efter Skat -630.21 -74.742 -77.211 -23.848 4.561 -68
Netto Indkomst Før Ekstra Ting -630.21 -74.742 -77.211 -23.848 4.561 -68
Netto Indkomst -630.21 -117.042 -77.211 -23.848 859.1 -64.08
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -630.21 -74.742 -77.211 -23.848 4.561 -68
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -630.21 -117.042 -77.211 -23.848 859.1 -64.08
Fortyndet Netto Indkomst -630.21 -117.042 -77.211 -23.848 859.1 -64.08
Fortyndet Vægtet Gennemsnit Aktier 165.985 174.427 177.061 179.039 191.678 182.852
Fortyndet EPS Uden Ekstraordinære Ting -3.79679 -0.4285 -0.43607 -0.1332 0.0238 -0.37189
Fortyndet Normaliseret EPS -1.45063 -0.89431 -0.61962 -0.22396 -0.17796 -0.37189
Totale Ekstraordinære Ting -42.3 0 854.539 3.92
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total omsætning 486.03 501.693 408.742 449.81 519.359
Omsætning 486.03 501.693 408.742 449.81 519.359
Kost af omsætning, Total 120.166 127.062 103.537 119.75 116.965
Bruttofortjeneste 365.864 374.631 305.205 330.06 402.394
Totale Driftsudgifter 460.944 490.021 461.961 515.69 382.032
Salgs/Generelle/Admin. Udgifter, Total 174.318 184.161 183.333 217.563 194.619
Forskning & Udvikling 148.725 161.107 157.869 161.092 160.836
Depreciation / Amortization 15.4 15.5 15.4 15.6 15.6
Usædvanlig Udgift (Indkomst) 0 0 0 0 -108
Other Operating Expenses, Total 2.335 2.191 1.822 1.685 2.012
Driftsindtægter 25.086 11.672 -53.219 -65.88 137.327
Renteindkomst (Udgift), Netto Ikke-Drift -2.716 0.479 -1.866 -0.752 -1.986
Andre, Netto 0.858 2.005 8.925 0.058 -1.154
Netto Indkomst Før Skat 23.228 14.156 -46.16 -66.574 134.187
Netto Indkomst Efter Skat 17.371 12.941 -36.494 -61.818 120.798
Netto Indkomst Før Ekstra Ting 17.371 12.941 -36.494 -61.818 120.798
Netto Indkomst 17.371 12.941 -36.494 -57.898 120.798
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 17.371 12.941 -36.494 -61.818 120.798
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 17.371 12.941 -36.494 -57.898 120.798
Fortyndet Netto Indkomst 17.371 12.941 -36.494 -57.898 120.798
Fortyndet Vægtet Gennemsnit Aktier 184.365 185.427 183.214 183.56 194.886
Fortyndet EPS Uden Ekstraordinære Ting 0.09422 0.06979 -0.19919 -0.33677 0.61984
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS 0.09422 0.06979 -0.19919 -0.33677 0.12096
Totale Ekstraordinære Ting 3.92
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Totale Nuværende Aktiver 1421.79 2207.14 2056.22 1942.14 2342.22 2274.39
Likvider og Kortsigtede Investeringer 789.677 1395.97 1084.31 753.807 1065.39 1013.88
Likvider & Lignende 408.33 598.028 493.982 437.446 649.158 587.276
Kortsigtede Investeringer 381.347 797.94 590.326 316.361 416.228 426.599
Totale Tilgodehavender, Netto 215.28 261.365 342.633 377.404 448.351 373.399
Accounts Receivable - Trade, Net 215.28 261.365 342.633 377.404 448.351 373.399
Total Inventory 355.126 475.775 530.871 680.275 698.548 776.669
Other Current Assets, Total 61.708 74.036 98.403 130.657 129.934 110.442
Total Assets 4023.69 4633.12 4427.13 4690.04 5848.02 6003.33
Property/Plant/Equipment, Total - Net 798.768 896.7 948.682 1070.3 1089.58 1081.88
Property/Plant/Equipment, Total - Gross 1141.36 1303.43 1421.32 1619.4 1725.18 1802.45
Accumulated Depreciation, Total -342.594 -406.734 -472.635 -549.1 -635.595 -720.574
Goodwill, Net 197.039 197.039 197.039 197.039 196.199 196.199
Intangibles, Net 553.78 517.51 491.808 456.58 417.271 388.652
Long Term Investments 572.711 385.785 235.864 411.978 285.473 507.793
Other Long Term Assets, Total 479.601 428.947 497.52 611.997 1517.28 1554.42
Total Current Liabilities 439.31 816.518 523.241 932.503 492.548 539.822
Payable/Accrued 198.53 161.652 208.119 240.981 191.429 193.003
Accrued Expenses 158.926 201.601 213.03 287.878 266.254 277.059
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 22.478 360.949 0 365.131 2.865 2.266
Other Current Liabilities, Total 59.376 92.316 102.092 38.513 32 67.494
Total Liabilities 1257.42 1824.46 1459.19 1567.66 1742.02 1732.58
Total Long Term Debt 660.761 813.521 830.417 492.946 1079.15 1081.04
Long Term Debt 660.761 813.521 830.417 486.238 1075.15 1079.08
Deferred Income Tax 0
Other Liabilities, Total 157.344 194.423 105.53 142.209 170.319 111.726
Total Equity 2766.27 2808.66 2967.94 3122.38 4106 4270.74
Common Stock 0.173 0.176 0.178 0.18 0.182 0.184
Additional Paid-In Capital 4288.11 4483.22 4669.93 4832.71 4993.41 5191.5
Retained Earnings (Accumulated Deficit) -1520.51 -1637.55 -1694.13 -1720.71 -861.609 -925.689
Other Equity, Total -1.505 -34.463 -6.113 6.638 -29.867 6.116
Total Liabilities & Shareholders’ Equity 4023.69 4633.12 4427.13 4690.04 5848.02 6003.33
Total Common Shares Outstanding 172.648 175.844 178.253 179.838 181.741 183.913
Unrealized Gain (Loss) -2.722 -1.917 3.565 3.889 -1.373
Capital Lease Obligations 6.708 4.006 1.96
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Totale Nuværende Aktiver 2288.77 2357.84 2311.57 2274.39 2394.02
Likvider og Kortsigtede Investeringer 1087.49 1123.4 1079.48 1013.88 1056.24
Likvider & Lignende 667.313 641.533 617.143 587.276 605.44
Kortsigtede Investeringer 420.178 481.864 462.333 426.599 450.798
Totale Tilgodehavender, Netto 396.097 424.419 374.937 373.399 430.147
Accounts Receivable - Trade, Net 396.097 424.419 374.937 373.399 430.147
Total Inventory 713.929 710.975 749.406 776.669 786.356
Other Current Assets, Total 91.249 99.046 107.751 110.442 121.283
Total Assets 5805.05 5898.5 5977.48 6003.33 6062.71
Property/Plant/Equipment, Total - Net 1022.47 1026.58 1024.79 1035.46 1039.54
Property/Plant/Equipment, Total - Gross 1679.77 1704.7 1724.7 1756.04 1780.71
Accumulated Depreciation, Total -657.296 -678.126 -699.915 -720.574 -741.167
Goodwill, Net 196.199 196.199 196.199 196.199 196.199
Intangibles, Net 405.903 394.298 388.487 388.652 374.251
Long Term Investments 321.127 350.237 466.618 507.793 462.827
Other Long Term Assets, Total 1570.58 1573.35 1589.81 1600.83 1595.86
Total Current Liabilities 430.035 443.344 514.898 539.822 490.418
Payable/Accrued 165.001 176.073 203.321 203.467 187.81
Accrued Expenses 209.203 207.005 241.535 268.861 214.435
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 55.831 60.266 70.042 67.494 88.173
Total Liabilities 1643.04 1656.93 1711.33 1732.58 1671.39
Total Long Term Debt 1076.13 1077.11 1078.09 1079.08 1080.06
Long Term Debt 1076.13 1077.11 1078.09 1079.08 1080.06
Other Liabilities, Total 136.881 136.471 118.335 113.686 100.913
Total Equity 4162.01 4241.57 4266.15 4270.74 4391.31
Common Stock 0.183 0.183 0.184 0.184 0.185
Additional Paid-In Capital 5010.62 5083.83 5133.74 5191.5 5206.29
Retained Earnings (Accumulated Deficit) -844.238 -831.297 -867.791 -925.689 -804.891
Unrealized Gain (Loss) 2.387 1.821 1.218 -1.373 -9.264
Other Equity, Total -6.941 -12.967 -1.204 6.116 -1.002
Total Liabilities & Shareholders’ Equity 5805.05 5898.5 5977.48 6003.33 6062.71
Total Common Shares Outstanding 182.671 183.322 183.567 183.913 184.902
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Netto indkomst/Startlinje -630.21 -117.042 -77.211 -23.848 859.1 -64.08
Likvider Fra Driftsaktiviteter -227.837 -8.757 20.208 48.262 85.365 304.536
Likvider Fra Driftsaktiviteter 96.912 87.861 95.671 105.3 105.172 108.039
Deferred Taxes -228.054 44.464 -68.378 -82.76 -888.907 -15.608
Ikke-Likvide Ting 693.791 69.923 119.546 150.662 234.417 210.151
Cash Taxes Paid 95.857 23.895 16.676 9.726 8.977 18.153
Likvid Rente Betalt 8.643 8.544 11.623 8.552 12.178 10.395
Ændringer i Driftskapital -160.276 -93.963 -49.42 -101.092 -224.417 66.034
Likvider fra Investeringsaktiviteter -484.047 -305.459 264.351 -31.026 -53.621 -366.313
Kapitaludgifter -148.38 -199.219 -144.62 -163.406 -137.519 -119.225
Andre Investerings-Cash-Flow-Ting, Total -335.667 -106.24 408.971 132.38 83.898 -247.088
Likvider fra Financieringsaktiviteter 727.108 507.145 -388.007 -74.674 181.118 -0.048
Financiering af Cash-Flow-Ting -60.057 -35.427 -80.542 -101.198 -44.638 -46.203
Udstedelse (Pensionering) af Aktier, Netto 787.165 60.859 67.488 31.611 21.913 49.194
Udenlandsk Børs Effekter -3.934 -3.231 -0.598 0.902 -1.15 -0.057
Netto Ændring i Likviditet 11.29 189.698 -104.046 -56.536 211.712 -61.882
Udstedelse (Pensionering) af Gæld, Netto 481.713 -374.953 -5.087 203.843 -3.039
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 17.371 30.312 -6.182 -64.08 120.798
Cash From Operating Activities 113.512 196.296 293.356 304.536 -45.431
Cash From Operating Activities 27.983 55.214 82.053 108.039 27.343
Deferred Taxes 3.335 1.204 -12.02 -15.608 4.8
Non-Cash Items 56.553 111.414 163.355 210.151 -61.68
Cash Taxes Paid 2.998 10.159 15.531 18.153 1.316
Cash Interest Paid 1.465 5.195 6.673 10.395 1.422
Changes in Working Capital 8.27 -1.848 66.15 66.034 -136.692
Cash From Investing Activities -70.788 -191.045 -310.892 -366.313 87.782
Capital Expenditures -28.254 -54.506 -74.866 -119.225 -30.675
Other Investing Cash Flow Items, Total -42.534 -136.539 -236.026 -247.088 118.457
Cash From Financing Activities -24.364 -13.413 -14.444 -0.048 -25.28
Financing Cash Flow Items -29.097 -39.112 -44.829 -46.203 -32.949
Issuance (Retirement) of Stock, Net 5.817 27.64 32.877 49.194 8.235
Issuance (Retirement) of Debt, Net -1.084 -1.941 -2.492 -3.039 -0.566
Foreign Exchange Effects -0.205 0.537 -0.035 -0.057 1.093
Net Change in Cash 18.155 -7.625 -32.015 -61.882 18.164
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
PRIMECAP Management Company Investment Advisor 9.4838 17625505 -52980 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.1613 17026106 263453 2022-09-30 LOW
Dodge & Cox Investment Advisor/Hedge Fund 7.9494 14773963 -233100 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3137 9875458 113895 2022-09-30 LOW
Baker Bros. Advisors LP Hedge Fund 4.1004 7620494 0 2022-09-30 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 3.0607 5688259 129970 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.8402 5278438 -117928 2022-09-30 LOW
Viking Global Investors LP Investment Advisor/Hedge Fund 2.7437 5099164 46571 2022-09-30 MED
Capital Research Global Investors Investment Advisor 2.6563 4936740 1394 2022-09-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 2.2221 4129724 -71509 2022-09-30 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 1.9131 3555555 271555 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.353 2514523 42707 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.2642 2349540 223693 2021-12-31 LOW
Parnassus Investments, LLC Investment Advisor 1.2583 2338529 -227551 2022-12-31 LOW
Barclays Bank PLC Investment Advisor 1.1309 2101767 182659 2022-09-30 MED
Palo Alto Investors LP Hedge Fund 1.0634 1976265 -85108 2022-09-30 LOW
Millennium Management LLC Hedge Fund 1.0085 1874272 348269 2022-09-30 HIGH
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.9306 1729432 1607478 2022-09-30 HIGH
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 0.924 1717310 17600 2022-09-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.7732 1437057 -102057 2022-09-30 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group
+485000+

Handlende

65000+

Månedlkige, aktive klienter

$48000000+

Månedlig investeringsvolumen

$28000000+

Hævet hver måned

Handelslommeregner

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Handelskurtage
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Gearing
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

BioMarin Company profile

Om BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc er en bioteknologisk virksomhed. Virksomheden udvikler og markedsfører terapier til mennesker med alvorlige og livstruende sjældne sygdomme og medicinske tilstande. Virksomhedens portefølje består af kommercielle produkter og flere kliniske og prækliniske produktkandidater til behandling af forskellige sygdomme. Selskabets kommercielle produkter omfatter Aldurazyme (laronidase), Brineura (cerliponase alfa), Kuvan (sapropterin dihydrochlorid), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Vimizim (elosulfase alfa) og Voxzogo (vosoritid). Virksomhedens pipeline omfatter Valoctocogene Roxaparvovec til behandling af svær hæmofili A, Vosoritid til behandling af akondroplasi, BMN 307 til behandling af phenylketonuri (PKU) og BMN 331 til behandling af hereditært angioødem (HAE).

Industry: Biopharmaceuticals

105 Digital Dr
NOVATO
CALIFORNIA 94949
US

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Long position, gebyr natten over -0.1138%
Short position, gebyr natten over 0.0796%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.005

XRP/USD

0.40 Price
-3.600% 1D Chg, %
Long position, gebyr natten over -0.0500%
Short position, gebyr natten over 0.0140%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.00276

US100

12,566.80 Price
-0.450% 1D Chg, %
Long position, gebyr natten over -0.0183%
Short position, gebyr natten over 0.0071%
Gebyr natten over, tid 22:00 (UTC)
Spænd 3.0

BTC/USD

23,016.40 Price
-1.780% 1D Chg, %
Long position, gebyr natten over -0.0500%
Short position, gebyr natten over 0.0140%
Gebyr natten over, tid 22:00 (UTC)
Spænd 60.00

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel